SBS Calendar
Take advantage of the unique opportunity to engage 41 CEPH-accredited schools of public health at one convenient location during the American Public Health Association (APHA) 137th Annual Meeting and Exposition, at the Pennsylvania Convention Center. Visit Day at APHA is designed for you to discover the rewards of a career in public health.
Please join us for a special seminar presented by Michael L. Jackson, PhD, MPH.
Peggy Hannon, PhD
Please RSVP
Professor
Environmental and Occupational Health Sciences
University of Washington
biography
additional information
Peter J. Neumann, ScD
Director of the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA
David Cutler, PhD
Otto Eckstein Professor of Applied Economics, Harvard University Department of Economics and Kennedy School of Government
Health Care Reform: The Real Story
Reception follows in the Health Sciences Lobby
Please be a part of the effort of the Combined Fund Drive (CFD)!
The CFD benefits many great charities all over the world, one of which is under
the guidance and leadership of one of our own faculty members, Sharyne Thornton.
Sharyne is the current Executive Director for the International District Housing
Alliance, improving the quality of life of Chinatown/International District
residents and Asian Pacific Islanders of greater Seattle by providing
community-building and housing-related services.
Sharyne will talk about IDHA and tell us how we can help through the
CFD. Please come to find out more information about the services IDHA provides
for the community and how we can contribute. Also, a representative from the CFD will be there to answer any questions.
IDHA website:
http://www.apialliance.org/
What is the CFD?
http://www.washington.edu/uwcfd/about-campaign/index.html
Thank you for your time and hope to see you there!
Sharon Kaufman, PhD
Institute for Health & Aging; Dept. of Social and Behavioral Sciences; and Dept. of Anthropology, History, and Social Medicine; University of California, San Francisco
Dr. Sharon Kaufman is a medical anthropologist whose current primary area of
research (supported by NIA/NIH) centers on the kind of people we are becoming in an aging society in which medical technique plays a central and powerful role.
She is particularly interested in the ways in which medical techniques link
ethics to intervention and consumption, and is currently investigating the ways
in which life-extending medical procedures in late life shape knowledge and
practices surrounding normal aging, lifespan, family and obligation. Her many
publications include her prizewinning book: And a Time to Die: How American
Hospitals Shape the End of Life (2005).
New Meeting Format (started 10/27/09):
- 3:00-3:30pm Regular Faculty ONLY
- 3:30-4:30pm All Faculty & Staff
- 4:30-5:00pm Social
Claus Portner
Assistant Professor, Department of Economics, University of Washington
Thomas Schwarz, PhD
Professor of Neurology and Neurobiology, Harvard Medical School/Children's Hospital, Department of Neurology (Neuroscience)
Associate Professor
University of Washington Law School
biography
additional information
Jaqueline Raetz, MD, Jane Huntington, MD, Valerie Ross, MS, Kavitha Chunchu, MD, Carol Charles, MSW
Keynote Speaker: David K. Wessner, President & CEO, Park Nicollet Health Services
Presentation followed by panel discussion, Q&A session, and reception.
Adrian Raftery
Blumstein-Jordan Professor of Statistics and Sociology, Department of Statistics, University of Washington
Dr. Hugo Vilchis is the Director of the Border Epidemiology & Environmental Health Center at New Mexico State University. He is Associate Professor at New Mexico State University with the Health Science Department (College of Health and Social Services) and with the Molecular Biology Graduate program. He is also a Professor at El Colegio de Chihuahua and the Universidad Autónoma de Coahuila, higher education and research institutions in Mexico.
He obtained his medical degree from the National Autonomous University of Mexico in 1982 and his MPH from the School of Public Health of Mexico in 1985. Dr. Vilchis studied Epidemiology and Surveillance in Brazil in 1986.
Dr. Vilchis' public health career started in Mexico City in 1980 working for the General Directorate of Epidemiology, Mexican Secretary of Health. He was Department Chief of the National Immunization Programs in Mexico and during his tenure, children immunization rates rose to 90%. In 1989, he was appointed to the Pan American Health Organization, first as the National Advisor for the Immunization Program in Mexico and in 1992 as the Medical Epidemiologist of the Field Office in El Paso, Texas. In 1996, Dr. Vilchis joined New Mexico State University and the NM Office of Border Health, where he developed the Border Epidemiology & Environmental Health Center.
He has been working on many different projects involving epidemiology, surveillance, community health, and international health. Dr. Vilchis obtained his expertise working in the United States and Latin American countries like Mexico, Brazil, and Guatemala, among many others.
Research Committee Members are:
Janice Bell, Diana Buist, Michael Chapko, Doug Conrad, Bonnie Duran, Todd Edwards, Peggy Hannon, Paul Hebert, Larry Kessler, Branko Kopjar, Paul Kraegel, Ian Painter, Donald Patrick/Chair, Sheryl Schwartz
Elizabeth (Betz) Halloran
Professor in Biostatistics, Fred Hutchinson Cancer Research Center
Professor, Env. and Occ. Health Sciences
Adjunct Professor, Evans School
biography
additional information
This is the first educational seminar sponsored by
the Hiroshima International Council for Health Care of
Radiation-Exposed (HICARE) in Seattle. The Council has been sending a
medical team to the Pacific Northwest to provide A-bomb survivors with
health examinations every other year. Another important mission is to
educate the people in the world about the danger of and health effects
from A-bombs, in order to prevent the future use of nuclear weapons in
the world. It is a rare and important opportunity to listen to medical
and research experts who have been directly involved with A-bomb
survivors in Hiroshima and Nagasaki.
Speakers:
- Introduction
by Dr. Tsukasa Namekata (Clinical Associate Professor, Dept. of Health
Services, University of Washington and Director, Pacific Rim Disease
Prevention Center; and)
- Outline
of damages made by A-bomb in Hiroshima by Dr. Shizuteru Usui
(President, Hiroshima Prefectural Medical Association; and Director,
Hiroshima International Council for Health Care of Radiation-Exposed
(HICARE))
- Outline of Hiroshima International
Council for Health Care of the Radiation-exposed (HICARE) by Dr. Hiroo
Dohy (President, Hiroshima Red Cross Hospital & Atomic-bomb
Survivors Hospital; and President, HICARE)
- Effects of A-bomb Radiation on Human
Body by Dr. Kazunori Kodama (Chief Scientist, Radiation Effects
Research Foundation; President, Japan Epidemiological Association;
Executive Secretary, HICARE)
- Review
and Recommendation s Regarding Examination Projects for survivors in
North America for Past 32 years ― for Better Health of the Survivors in
NA― by Dr. Makoto Matsumura (Board-Director of Hiroshima Prefectural Medical Association)
- Concluding remarks by Dr. Scott Davis (Professor and Chair, Dept. of Epidemiology, University of Washington)
Parking is available at the S1 parking lot. When passing by the S1 Gate - please let the attendant know that you will be attending the seminar called"A-bomb Symposium". You pay on your way out.
Parking fee information: http://www.washington.edu/facilities/transportation/commuterservices/fees/gatehouse-permits
Nicole L. Glazer, PhD, Epidemiologist, UW, CHRU
Brief bio: Dr. Glazer received her Ph.D. in epidemiology from the University of Washington. She currently works as a cardiovascular epidemiologist at the UW Cardiovascular Health Research Unit. Her areas of interest include genetics, biomarkers and pharmacoepidemiology. In her post-graduate work she has mostly focused on genome-wide association studies.
Recommended reading:
- Pearson TA, Manolio TA. How to interpret a genome-wide association study. JAMA. 2008;299:1335-44.
- Newton-Cheh C, et al. Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet. 2009;41:399-406.
Miruna Petrescu-Prahova
Post-Doc Researcher, Department of Statistics, University of Washington
Annette Fitzpatrick, PhD
Update on the PRC Cardiovascular Health Intervention Research and Translation Network (CHIRTN)
Communicating with Pictures: Using Photovoice to Portray Perceptions of Cardiovascular Disease in Asian Immigrants
Please RSVP
Departmental holiday potluck for faculty and staff. (details to come)
Mark Doescher, MD, MSPH
Director of WWAMI Rural Health Research Center and Center for Health Workforce Studies
Meeting Schedule:
- 3:00-3:30pm Regular Faculty ONLY
- 3:30-4:30pm All Faculty & Staff
- 4:30-5:00pm Social
AHRQ Issues Funding Opportunity Announcement (R01) for Comparative Effectiveness Research
Dear Colleague:
We are pleased to inform you about a Funding Opportunity Announcement (FOA) issued on September 25 by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ). RFA-HS-10-003, Clinical and Health Outcomes Initiative in Comparative Effectiveness (CHOICE) Grants (R01), is supported by $100 million in funds provided to AHRQ under the American Recovery and Reinvestment Act of 2009.
The FOA invites grant applications for new comparative effectiveness research projects aimed at generating new knowledge to help inform decisionmaking in priority areas of clinical care. Projects should be focused on developing new scientific evidence that will fill important knowledge gaps and on generating critical insights into the comparative clinical effectiveness of health care interventions. Applications should address the outcomes and effectiveness of assessments across population groups that are often underrepresented in medical research. The impact of these studies should have a high likelihood of creating major advancements in clinical care. The initiative will emphasize projects that define research gaps and studies that are designed to produce actionable results.
AHRQ anticipates making 10 awards that together total $100 million, contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the proposed research will vary across applications, it is anticipated that each award's size and duration will vary. Applications may be up to 3 years in duration, with a total budget not to exceed $10 million over the 3 years. While total annual costs may vary over the award period, the maximum cost in any one year cannot exceed $4 million. Funding beyond the first year will be contingent upon the Agency's acceptance of the grantee's annual progress report. Applications are due on December 16, 2009.
Questions about this FOA can be submitted to: CHOICEgrants@ahrq.hhs.gov
Dear Colleague:
We are pleased to inform you about a Funding Opportunity Announcement (FOA) issued on September 25 by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ). RFA-HS-10-004, Innovative Adaption and Dissemination of AHRQ Comparative Effectiveness Research Products (iADAPT) (R18) is supported by $29.5 million in funds provided to AHRQ under the American Recovery and Reinvestment Act of 2009.
The FOA invites grant applications for new projects to extend the reach and impact of Comparative Effectiveness Research Reviews and associated products, particularly Comparative Effectiveness Research Summary Guides, which are prepared by the John M. Eisenberg Clinical Decisions and Communications Science Center, part of the AHRQ Effective Health Care Program. AHRQ seeks innovative efforts to adapt the content and/or delivery mechanism of one or more of its current or forthcoming comparative effectiveness research products, particularly summary guides. Adaptations should aim to increase the impact and effective use of one or more comparative effectiveness research products by developing, implementing, and evaluating product adaptations that target three important audiences: stakeholders, systems, and settings. The adaptations may involve customizing the original comparative effectiveness research contents to a specialized clinical audience of potential users or translating the Comparative Effectiveness Research Summary Guides for underserved patient and consumer populations who have limited access to medication information on the Internet. These consumers and patients are more likely to get health care information and advice provided through traditional means, such as neighborhood, community, or faith-based groups. Adaptations may address the presentation of the content and/or mechanisms by which the contents are delivered or used.
AHRQ anticipates making 20 to 25 awards that together total $29.5 million, contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the proposed research will vary across applications, it is anticipated that each award's size and duration will vary. Applications may be up to 3 years in duration, with a total budget not to exceed $1.5 million over the 3 years. While total annual costs may vary over the period of the award, the maximum cost in any one year cannot exceed $1 million. Funding beyond the first year will be contingent upon the Agency's acceptance of the annual progress report. Applications are due on December 16, 2009.
Questions about this FOA can be submitted to: iADAPTgrants@ahrq.hhs.gov
Research Committee Members are:
Janice Bell, Diana Buist, Michael Chapko, Doug Conrad, Bonnie Duran, Todd Edwards, Peggy Hannon, Paul Hebert, Larry Kessler, Branko Kopjar, Paul Kraegel, Ian Painter, Donald Patrick/Chair, Sheryl Schwartz
Research Committee Members are:
Janice Bell, Diana Buist, Michael Chapko, Doug Conrad, Bonnie Duran, Todd Edwards, Peggy Hannon, Paul Hebert, Larry Kessler, Branko Kopjar, Paul Kraegel, Donald Patrick/Chair, Sheryl Schwartz
Research Committee Members are:
Janice Bell, Diana Buist, Michael Chapko, Doug Conrad, Bonnie Duran, Todd Edwards, Peggy Hannon, Paul Hebert, Larry Kessler, Branko Kopjar, Paul Kraegel, Ian Painter, Donald Patrick/Chair, Sheryl Schwartz
